Prelude Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Sell |
|
|||||
|
2025
Q1 | $250K | Buy |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $78K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $7K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $3K | Sell |
|
|||||
|
2018
Q3 | $7K | Sell |
|
|||||
|
2018
Q2 | $71K | Sell |
|
|||||
|
2018
Q1 | $118K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $53K | Buy |
|